TCRT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Alaunos Therapeutics Inc (TCRT) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks strong positive catalysts, has weak financial performance, and no significant trading signals or trends to justify an immediate purchase.
The technical indicators are bearish. The MACD histogram is negative and contracting, RSI is neutral at 35.938, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 2.755), but there is no clear upward momentum.
NULL identified. No recent news, no significant hedge fund or insider activity, and no recent congress trading data.
Weak financial performance in 2025/Q4, with revenue dropping 25% YoY and EPS declining 17.39% YoY. The stock has bearish technical indicators and lacks significant trading signals.
In 2025/Q4, revenue dropped by 25% YoY to 3000, net income improved slightly but remains negative at -893000 (up 20.35% YoY), and EPS declined by 17.39% to -0.38. Gross margin remained flat at 100%. Overall, financials are weak and do not indicate growth.
No data on analyst ratings or price target changes. Wall Street sentiment is neutral, with no significant pros or cons identified.
